Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000376803

Medchemexpress LLC MDA 19 (BZO-HEXOXIZID) | 1048973-47-2 | C21H23N3O2 | 50 MG
SDP

Catalog No. 5000376803
Encompass_Preferred

MDA 19 is a potent and selective agonist of human cannabinoid receptor 2 (CB2), with a Ki of 43.3 nM. It exhibits antiallodynic effects in a rat model of neuropathic pain and does not affect rat locomotor activity.

  • Potent and selective agonist of human cannabinoid receptor 2 (CB2)
  • Exhibits antiallodynic effects in a rat model of neuropathic pain
  • Does not affect rat locomotor activity
  • Higher affinity at human CB2 (Ki = 43.3 nM) than human CB1
  • Nearly 70-fold higher affinity at rat CB2 (Ki = 16.3 nM) than rat CB1

Catalog No. 50-003-76803 Supplier Medchemexpress LLC Supplier No. HY1545150MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MDA 19 is a potent and selective agonist of human cannabinoid receptor 2 (CB2), with a Ki of 43.3 nM. It exhibits antiallodynic effects in a rat model of neuropathic pain and does not affect rat locomotor activity.

  • Potent and selective agonist of human cannabinoid receptor 2 (CB2)
  • Exhibits antiallodynic effects in a rat model of neuropathic pain
  • Does not affect rat locomotor activity
  • Higher affinity at human CB2 (Ki = 43.3 nM) than human CB1
  • Nearly 70-fold higher affinity at rat CB2 (Ki = 16.3 nM) than rat CB1

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.